Serious toxicities associated with chemotherapy.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects; D001761:Bleomycin / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D004630:Emergencies; D045166:Estradiol Congeners / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*; D009607:Nitrosourea Compounds / Q000009:adverse effects; D008926:Plicamycin / Q000009:adverse effects; D045165:Testosterone Congeners / Q000009:adverse effects; D014748:Vinca Alkaloids / Q000009:adverse effects
D000970:Antineoplastic Agents; D045166:Estradiol Congeners; D009607:Nitrosourea Compounds; D045165:Testosterone Congeners; D014748:Vinca Alkaloids; D001761:Bleomycin; D004317:Doxorubicin; D003520:Cyclophosphamide; D001215:Asparaginase; D008926:Plicamycin; D002945:Cisplatin; D008727:Methotrexate; D003630:Daunorubicin